Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metadoxine for the treatment of MetALD
TCTR20250322001Phase 2Recruiting
- Sponsor
- Department of Medicine, Phramongkutklao Hospital
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Metadoxine in metabolic alcohol-associated liver disease (MetALD), sponsored by Department of Medicine, Phramongkutklao Hospital. Started Jul 2025; status: recruiting.
02
Drugs
Metadoxine
03
Conditions
metabolic alcohol-associated liver disease (MetALD)
Beyond the preview
Go deeper on TCTR20250322001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250322001.